Report Highlights
The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023.
Report Includes
- 26 data tables and 34 additional tables
- Detailed overview of the global markets for pharmaceuticals for women's health
- Country specific data and analysis for United States, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
- A look at the regulatory environment which has been a driving force in the drug development industry
- Information on competitor initiatives, and information with regard to demand for specialty chemicals used to develop new products and for new applications
- A relevant patent analysis within the sector
- Comprehensive company profiles of major Players in the Market including AbbVie Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc.
Report Scope
While women’s health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. This report does not focus on drugs for infertility, diagnostic and drug technologies for breast cancer or therapies and diagnostics for ovarian cancer. However, we have individuals reports which discusses the scope of these health concerns in detail. The report codes for these reports are listed below:
- PHM194A Drugs for Infertility: Global Markets.
- HLC143B Therapies and Diagnostics for Ovarian Cancer: Global Markets.
- HLC209A U.S. Fertility Clinics Market.
- HLC106B Breast Cancer Diagnostic and Drug Technologies: Global Markets.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Companion Diagnostics: Technologies and Markets (BIO077F)
- Global Markets, Technologies and Materials for Thin and Ultrathin Films (SMC057D)
- Molecular Farming: Global Markets (CHM187A)
- Exosome Diagnostics, Therapeutics and Research Tools: Global Markets (BIO149E)
- Global Skin Allergy Testing Market (MDS104A)
Related Reports
U.S. Fertility Clinics Market
The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.
Therapeutics for Women's Health: Technologies and Global Markets
The global market for women’s health therapeutics should grow from $54.4 billion in 2021 to $70.8 billion by 2026 with a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
Breast Cancer Diagnostic and Drug Technologies: Global Markets
The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.
Femtech: Empowering Women's Health
Over the last year, a new $1.1 billion category of tech emerged with the purpose of helping women understand their health and well-being better than ever before: Femtech. As women have come to view fertility as a measure of their overall health—an interest no longer reserved exclusively for the prenatal set—more companies are disrupting the process of fertility awareness and contraception, as mbg investigated earlier this year, making cycle tracking a whole lot easier. Fertility apps like Daysy and Kindara come with a Bluetooth thermometer that syncs with your phone, making early-morning temperature readings super simple to record and decipher. Other companies like ava aim to make the whole experience less invasive (if thermometers aren’t your thing) by tracking vital signs via wrist wearables and delivering predictions and insights about fertility to their phone app. Some startups like Glowfocus solely on helping women get pregnant, but even Glow has a sister app, Eve, to track periods and sexual health.
Recent Reports
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More